Clinical trials in Sankt Veit Im Pongau

Comprehensive clinical research focusing on hepatoblastoma and hepatocellular carcinoma in pediatric patients, evaluating various treatment approaches based on risk stratification.

• Very Low-Risk and Low-Risk Studies
• Intermediate Risk Treatments
• High-Risk Management Protocols

The trials aim to optimize treatment strategies while collecting valuable biological and toxicity data to enhance patient outcomes.

Investigation of multiple chemotherapy combinations including cisplatin-based regimens and innovative drug combinations for treating pediatric liver tumors.

• Standard vs. Modified Protocols
• Novel Drug Combinations
• Risk-Adapted Approaches

Research focuses on comparing treatment efficacy and toxicity profiles across different therapeutic strategies.

Evaluation of targeted therapies including specific protocols for resected and unresected liver cancers in pediatric patients.

• Post-Surgery Protocols
• Metastatic Disease Management
• Combination Therapy Assessment

Studies examine the effectiveness of various treatment combinations and their timing in different patient groups.